On Tuesday, Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) was -10.95% drop from the session before settling in for the closing price of $10.59. A 52-week range for ARCT has been $10.35 – $45.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 301.31% over the last five years. When this article was written, the company’s average yearly earnings per share was at -64.73%. With a float of $24.37 million, this company’s outstanding shares have now reached $27.00 million.
The firm has a total of 176 workers. Let’s measure their productivity. In terms of profitability, gross margin is 105.33%, operating margin of -55.8%, and the pretax margin is -58.49%.
Arcturus Therapeutics Holdings Inc (ARCT) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Arcturus Therapeutics Holdings Inc stocks. The insider ownership of Arcturus Therapeutics Holdings Inc is 10.14%, while institutional ownership is 89.74%. The most recent insider transaction that took place on Oct 15 ’24, was worth 249,121. In this transaction Chief Scientific Officer & COO of this company sold 12,000 shares at a rate of $20.76, taking the stock ownership to the 435,334 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Officer proposed sale 12,000 for $20.76, making the entire transaction worth $249,121.
Arcturus Therapeutics Holdings Inc (ARCT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -64.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 48.92% during the next five years compared to -6.84% drop over the previous five years of trading.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
You can see what Arcturus Therapeutics Holdings Inc (ARCT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.00, a number that is poised to hit -1.10 in the next quarter and is forecasted to reach -3.84 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
Analysing the last 5-days average volume posted by the [Arcturus Therapeutics Holdings Inc, ARCT], we can find that recorded value of 0.46 million was better than the volume posted last year of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 4.55%. Additionally, its Average True Range was 1.04.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 0.16%, which indicates a significant decrease from 0.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.35% in the past 14 days, which was lower than the 75.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.31, while its 200-day Moving Average is $19.17. Now, the first resistance to watch is $10.14. This is followed by the second major resistance level at $10.86. The third major resistance level sits at $11.22. If the price goes on to break the first support level at $9.06, it is likely to go to the next support level at $8.70. Should the price break the second support level, the third support level stands at $7.98.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
There are 27,120K outstanding shares of the company, which has a market capitalization of 255.74 million. As of now, sales total 152,310 K while income totals -80,940 K. Its latest quarter income was 22,770 K while its last quarter net income were -30,010 K.
